Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Narendranath Epperla, MD, MS
Videos
08/17/2023

Featuring Narendranath Epperla, MD, MS

Featuring Narendranath Epperla, MD, M...
Narendranath Epperla, MD, MS, shares findings assessing the potential significance of DTI for predicting outcomes for patients with newly diagnosed MCL.
Narendranath Epperla, MD, MS, shares findings assessing the potential significance of DTI for predicting outcomes for patients with newly diagnosed MCL.
Narendranath Epperla, MD, MS,...
08/17/2023
Oncology
Susan M. O'Brien, MD
Videos
08/16/2023

Featuring Susan M. O'Brien, MD

Featuring Susan M. O'Brien, MD ...
At the 2023 EHA meeting in Frankfurt, Germany, Susan M. O'Brien, MD, provided insights into the latest frontline therapeutic options for patients with chronic lymphocytic leukemia.
At the 2023 EHA meeting in Frankfurt, Germany, Susan M. O'Brien, MD, provided insights into the latest frontline therapeutic options for patients with chronic lymphocytic leukemia.
At the 2023 EHA meeting in...
08/16/2023
Oncology
Gerald Prager, MD, Medical University of Vienna
Videos
08/11/2023

Featuring Gerald Prager, MD

Featuring Gerald Prager, MD
At the 2023 World Congress on Gastrointestinal Cancers, Gerald Prager, MD, presents data on a trial evaluating trifluridine/tipiracil plus bevacizumab for patients with refractory metastatic colorectal cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Gerald Prager, MD, presents data on a trial evaluating trifluridine/tipiracil plus bevacizumab for patients with refractory metastatic colorectal cancer.
At the 2023 World Congress on...
08/11/2023
Oncology
Anna Wagner, MD, University of Lausanne
Videos
08/11/2023

Featuring Anna Wagner, MD

Featuring Anna Wagner, MD
At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.
At the 2023 World Congress on...
08/11/2023
Oncology
Zev Wainberg, MD, University of California - Los Angeles
Videos
08/10/2023

Featuring Zev Wainberg, MD

Featuring Zev Wainberg, MD
At the 2023 World Congress on Gastrointestinal Cancers, Zev Wainberg, MD, presents data from the NAPOLI 3 study, evaluating NALIRIFOX in the first-line setting for patients with metastatic pancreatic ductal adenocarcinoma.
At the 2023 World Congress on Gastrointestinal Cancers, Zev Wainberg, MD, presents data from the NAPOLI 3 study, evaluating NALIRIFOX in the first-line setting for patients with metastatic pancreatic ductal adenocarcinoma.
At the 2023 World Congress on...
08/10/2023
Oncology
Akihito Kawazoe, MD, National Cancer Center East - Japan
Videos
08/10/2023

Featuring Akihito Kawazoe, MD

Featuring Akihito Kawazoe, MD
At the 2023 World Congress on Gastrointestinal Cancers, Akihito Kawazoe, MD, shared results from the phase 3 LEAP-017 trial, evaluating lenvatinib plus pembrolizumab among previously treated patients with metastatic colorectal cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Akihito Kawazoe, MD, shared results from the phase 3 LEAP-017 trial, evaluating lenvatinib plus pembrolizumab among previously treated patients with metastatic colorectal cancer.
At the 2023 World Congress on...
08/10/2023
Oncology
Andrea Bullock, MD, Harvard Medical School
Videos
08/10/2023

Featuring Andrea Bullock, MD

Featuring Andrea Bullock, MD
At the 2023 World Congress on Gastrointestinal Cancers, Andrea Bullock, MD, discussed the expanded phase 1 trial of bostensilimab plus balstilimab for heavily pretreated, metastatic microsatellite stable colorectal cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Andrea Bullock, MD, discussed the expanded phase 1 trial of bostensilimab plus balstilimab for heavily pretreated, metastatic microsatellite stable colorectal cancer.
At the 2023 World Congress on...
08/10/2023
Oncology
Michael Pishvaian, MD, PhD, Johns Hopkins University
Videos
08/10/2023

Featuring Michael Pishvaian, MD, PhD

Featuring Michael Pishvaian, MD, PhD ...
At the 2023 World Congress on Gastrointestinal Cancers, Michael Pishvaian, MD, PhD, shared data from the first interim analysis of a phase 3 study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
At the 2023 World Congress on Gastrointestinal Cancers, Michael Pishvaian, MD, PhD, shared data from the first interim analysis of a phase 3 study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
At the 2023 World Congress on...
08/10/2023
Oncology
Leony Antoun, MD, Gustave Roussy Cancer Campus
Videos
08/09/2023

Featuring Leony Antoun, MD

Featuring Leony Antoun, MD
At the 2023 World Congress on Gastrointestinal Cancers, Leony Antoun, MD, discusses the impact of molecular profiling on survival among patients with advanced biliary tract cancers.
At the 2023 World Congress on Gastrointestinal Cancers, Leony Antoun, MD, discusses the impact of molecular profiling on survival among patients with advanced biliary tract cancers.
At the 2023 World Congress on...
08/09/2023
Oncology

Advertisement

Advertisement

Advertisement

Advertisement